Summary
This filing is an amendment (8-K/A) to a previous 8-K filed on October 25, 2007, by Bristol-Myers Squibb Company (BMY). The amendment clarifies and revises supplemental financial information related to the company's third-quarter 2007 results. Specifically, it includes updated net sales, months on hand, and estimated demand data for key products across its International Pharmaceutical, Nutritionals, and Other Health Care segments as of September 30, 2007. Investors should note that this amendment primarily provides revised historical data for key product metrics. The supplemental information, available via the company's website and incorporated by reference, offers a more detailed look at inventory levels and demand for BMY's products during the third quarter of 2007, comparing it to prior periods including June 30, 2007, and the same periods in 2006. This information can be valuable for understanding product performance and inventory management within the company's various business segments.
Key Highlights
- 1Amendment to a previous 8-K filing concerning third-quarter 2007 financial results.
- 2Revised supplemental financial information is provided, dated as of September 30, 2007.
- 3Includes updated net sales data for key products across International Pharmaceutical, Nutritionals, and Other Health Care segments.
- 4Provides revised 'months on hand' inventory data for key products as of September 30, 2007.
- 5Presents revised estimated demand information for key products as of September 30, 2007.
- 6Comparative data for net sales and months on hand is also included for June 30, 2007, September 30, 2006, and June 30, 2006.
- 7The revised supplemental information is incorporated by reference as Exhibit 99.2.